Eledon Pharmaceuticals (ELDN) Preferred Shares (2016)

Eledon Pharmaceuticals (ELDN) posted Preferred Shares of $19000.0 for Q4 2016.

Eledon Pharmaceuticals (ELDN) Preferred Shares (2016) Analysis & Trends

Eledon Pharmaceuticals' Preferred Shares history runs 1 years deep, the most recent figure standing at $19000.0 for Q4 2016.

Quarterly Preferred Shares changed N/A year-over-year to $19000.0 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $19000.0 (changed N/A YoY) and the FY2016 annual result came in at $19000.0, changed N/A from the prior year.
Preferred Shares was $19000.0 for Q4 2016 at Eledon Pharmaceuticals.
Across five years, Preferred Shares topped out at $19000.0 in Q4 2016 and bottomed at $19000.0 in Q4 2016.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Oculis Holding AG	67,462.92 Bn	67,462.64 Bn	-	-
2	Nanobiotix	1,941.00 Bn	1,940.94 Bn	-	-
3	Akari Therapeutics	1,132.35 Bn	1,132.35 Bn	-	-
4	BeOne Medicines	473.07 Bn	468.27 Bn	1.35 Bn	-
5	Vertex Pharmaceuticals	123.28 Bn	116.03 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	70.12 Bn	61.37 Bn	3.31 Bn	-
7	Belite Bio	62.40 Bn	62.40 Bn	-	-
8	Argenx Se	56.45 Bn	51.27 Bn	1.41 Bn	-
9	Alnylam Pharmaceuticals	37.49 Bn	34.48 Bn	959.66 Mn	-
10	Eledon Pharmaceuticals	412.03 Mn	412.03 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2016	19,000.00